626
MR. G. DISCOMBE: SULPHÆMOGLOBINÆMIA &
opening through the muscles and so remove the appendix. It was a gridiron appendicectomy superimposed on whatever type of herniotomy the surgeon might favour. In the procedure I describe the approach to the appendix is an integral part of the radical
cure. REFERENCES
Henry, A. K. (1936) Lancet, 1, 531. Torek, F. (1906) Ann. Surg. 43, 665.
SULPHÆMOGLOBINÆMIA FOLLOWING SULPHANILAMIDE TREATMENT BY GEORGE
DISCOMBE, B.Sc. Lond.
JUNIOR DEMONSTRATOR OF CHEMICAL PATHOLOGY, ST. BARTHOLEMEW’S HOSPITAL, LONDON
Prontosil Album and other brands of sulphanilamide (which is another name for p-aminobenzene-
SULPHANILAMIDE TREATMENT
Admitted on Jan. 1st, 1937, having had prontosil album for three days previously. Between Jan. 23rd and Feb. 15th received a total of 41-4 grammes of sulphanilamide, or 1-8 g. daily. Between Jan. 26th and Feb. 5th, received also 85 c.cm. prontosil soluble, or 2-125 g. Received magnesium sulphate at irregular intervals during this period. On Feb. 15th cyanosis of the lips and finger. nails was observed and on the 18th this was shown to be due to sulphsemoglobinaemia. The appearance of the patient at this time was characteristic ; the lips and nail. beds a cold blue, the face very pale ; the blood, even after shaking with air, remained a deep brown. It was indeed surprising to find her cheerful and talkative, not in the least worried or inconvenienced by her condition. No quantitative estimation was possible at this time, but the strength and persistence of the oc-band of sulphsemoglobin suggested that at least 40 per cent. of the haemoglobin present was in that inert form. CASE 2.-Miss B., aged 19. Mastoiditis ; Schwartze operation. Received 16-2 g. sulphanilamide between Feb. 9th and 19th (1-8 g. daily). Magnesium sulphate was given irregularly between Feb. 1st and 16th. On the 19th a faint band due to sulphsemoglobin was seen in the patient’s shed blood. There was no cyanosis and she left hospital on the 20th. CASE 3.-Miss C., aged 20. Lupus erythematosus; suspicion of pulmonary tuberculosis. Between Feb. 3rd and 18th received 27 g. sulphanilamide (1-8 g.. daily). Magnesium sulphate was given irregularly during this period. On Feb. 18th the cx.-band of sulphsemoglohin It was stronger was observed in the patient’s shed blood. than that shown by Case 2, but there was no cyanosis.
or sulphonamide, p-aminophenylsulphonamide, have been for used sulphonamide-P) generally some months. Trefouel and others (1935) and Fuller (1937) have shown that the soluble red azo-dye Prontosil Soluble (for injection) and the almost insoluble orange azo-dye Red Prontosil (oral) are bactericidal only after reduction to sulphanilamide. For this reason, and to avoid the pain associated with the injections of prontosil soluble, many workers have used sulphanilCASE 4.-D. E., aged 21. Mastoiditis; Schwartze amide alone, which can be taken by mouth. lateral sinus thrombosis; operation; osteomyelitis; At first this substance was believed to be non-
later it
toxic : cases
of
found to
produce occasional sulphsemoglobinaemia (Colebrook and Kenny was
1936a, three cases ; Foulis and Barr 1937, two cases ; Thomas 1937 ; Frost 1937, one case each). Frost did not use sulphanilamide, but prontosil soluble and N-benzyl sulphanilamide (Proseptasine) on which no other clinical reports have so far been published. The impression given by these three papers is that sulphsemoglobinsemia may be an occasional complication of sulphanilamide treatment, but that it is
unusual. When
of
extreme cyanosis following sulphanilamide recognised at St. Bartholomew’s Hospital, all patients who were receiving, or who had recently received, that substance were carefully examined. Of seven patients who had received over 5 grammes, six showed some degree of sulphaemoglobinsemia, three showing marked cyanosis. All these patients received the Prontosil brand of sulphanilamide. It appears that sulphanilamide is one of the most active drugs for the production of sulphsemoglobinaemia at our disposal. Of these seven patients, four (Nos. 1, 2, 3, and 4) received frequent doses of magnesium sulphate ; two of these (Nos. 1 and 4) developed cyanosis, while two (Nos. 2 and 3) showed a less degree of sulphaemoglobinsemia. One patient (No. 5) who developed cyanosis received only two doses of magnesium sulphate; and one (No. 6) which received no magnesium or sodium sulphate by mouth, but who did have dressings of sodium sulphate on a large gangrenous area, developed a very slight sulphsemoglobinsemia. The one patient (No. 7) who did not show any abnormal pigments in the blood, in spite of long-continued sulphanilamide treatment had no sulphates by mouth or as a dressing during the treatment. None of the patients affected has died ; one
case
was
all
are
recovering.
resection of the third right costal cartilage. Between Feb. 4th and 18th received 25-2 g. sulphanilamide (1-8 g. daily). Magnesium sulphate was given daily from Jan. 31st until Feb. 21st, except on the 12th. On the 18th obvious cyanosis was present, shown to be due to sulphsemoglobin by spectroscopic examination on the 20th. In this case the blood showed a brown tint, though less than that from Case 1. CASE 5.-Mrs. F., aged 51. Streptococcal abscess left thumb. Pus contained haemolytic streptococci. Between Feb. 13th and 26th received 25-2 g. sulphanilamide (1-8 g. daily). On Feb. 19th and 21st magnesium sulphate was given. Examination on Feb. 22nd had shown no evidence of sulphsemoglobinsemia; yet on the 26th the patient developed cyanosis, almost as severe as in Case 1. Her blood was brown, even to the untutored eye, and showed an intense cx-band of sulphoemoglobin. On Feb. 13th and 14th polyvalent antistreptococcal serum had been injected, and a serum reaction, with fever and an urticarial rash, developed on the 21st, 22nd, and 23rd. This may have some relation to the sudden onset of cyanosis. CASE 6.-Miss G., aged 15. Gangrene of chest following chicken-pox; pus contained hemolytic streptococci. Between Feb. 16th and 26th received 18 g. sulphanilamide (1-8 g. daily). No magnesium or sodium sulphate was given by mouth, but sodium sulphate dressings were applied to the gangrenous area. On Feb. 27th a faint, but easily seen, band of sulphsemoglobin was detected in the patient’s blood. CASE 7.-H. 1., aged 28. Osteomyelitis of the left maxilla. Between Jan. 25th and Feb. 18th he received 41-4 g. sulphanilamide (1-8 g. daily). No magnesium or sodium sulphate was given by mouth or in dressings. No sulphsemoglobin could be detected on the 18th or 23rd. CASE 8.-J. K., aged 10. Mastoiditis; Schwartze operation ; diabetes mellitus. This boy had only 2-7 g. sulphanilamide in three days and occasional doses of sodium and magnesium sulphates. No sulphsemoglobin was found, and this case is not included in the discussion on account of the small total dose and short period of administration. DISCUSSION
CASE REPORTS
aged 31. Panophthalmitis, multiple abscesses, following lobar pneumonia.
CASE I.-Mrs. A.,
streptococcal
The of sulphoemoglobinoemia in 6 out of the first 7 cases undergoing a moderately occurrence
627 treatment may b probable thati represents a genuine correlation, and that th occasional frank cyanosis is due to a quantitativ rather than qualitative difference in the action of th drug. The results presented here neither confirn nor deny the suggestion (Colebrook and Kenm 1936a, following van den Bergh and Revers 1931 that there is some connexion between magnesiun sulphate and the development of sulphaemoglobinaemÜ in sulphanilamide-treated patients. It is hope( that in the near future it will be possible to presentf series of cases treated with sulphanilamide whicl have had no sulphates either by mouth or as dressing The cyanosis caused by sulphsemoglobin Ü spectacular and alarming, but fortunately it does n01 produce any very serious consequences if the drug is stopped as soon as it is noticed ; in the three cases described here the patients were annoyed when attention was drawn to their condition, but not in the least perturbed. The only troublesome consequence is that the stay in hospital may be prolonged. All these three had fairly high haemoglobin figures, the lowest being 48 per cent. This condition may be dangerous, however, if the total haemoglobin percentage falls below about 30 per cent. (Haldane scale), for then cyanosis cannot occur and the drug responsible for the sulphaemoglobinaemia may be continued until over half the total haemoglobin present is changed to the inert form ; the plight of a patient with a streptococcal infection and about 15 per cent. active haemoglobin may easily be imagined. For this reason it is impossible to regard a careful watch for cyanosis as a sufficient precaution. The total haemoglobin should be determined and the patient’s blood should be examined regularly at intervals of less than four days (cf. Case 5). It is best to examine the shed blood, diluted with water or ammonia ; but quite small quantities of sulphaemoglobin can be detected by examining the blood in the lobe of the ear, using a torch and direct-vision spectroscope, as described by Harrison (p. 294). The necessary skill may be acquired by a little practice. There can be no doubt that in these cases sulphaemoglobin, not methaemoglobin, was present. It is found that dilution of blood with 0-4 per cent. ammonia destroys the a-band of methaemoglobin, but does not affect that of sulphaemoglobin; all specimens of blood were examined in water and in 0-4 per cent. ammonia. One or more other tests were made on each blood ; persistence of the a-band on treatment with reducing agents (ammonium sodium hydrosulphite) ; shift of the a-band sulphide, towards the violet on treatment with carbon monoxide; matching the a-band in the Hartridge reversion spectroscope with that of sulphaemoglobin artificially prepared from normal blood. One sample of blood was submitted to all these tests by Dr. G. A. Harrison
long
course
fortuitous ;
of it
sulphanilamide
seems
far
more
(Case 1). Thanks to the work of Trefouel et al. (1935), Colebrook et al. (1936), Fuller (1937), and others referred to in their papers, some knowledge is being obtained as to the mode of action and suitable uses of
sulphanilamide. So far outweigh its dangers,
its advantages seem heavily and its use is being limited and extended as more knowledge is obtained. It is, however, very important to be alert to all possible complications, and the possibility of grave anoxia due to unrecognised occurrence of sulphaemoglobinaemia should be borne in mind, while till more information is available, the administration of magnesium or sodium sulphate to sulphanilamide-treated patients should be forbidden. to
SUMMARY
(1) Sulphaemoglobinsemia is sequence of hitherto been is dangerous
a
commoner
co-u-
sulphanilamide treatment than has recognised. (2) Sulphsemoglobinsemia to anaemic patients. (3) Regular
spectroscopic examination of the blood of all patients receiving sulphanilamide is therefore advocated. My thanks are due to those members of the honorary staff of St. Bartholomew’s Hospital, Prof. J. Paterson Ross, Dr. A. C. Roxburgh, Mr. Sydney R. Scott, and Mr. R. Foster Moore, who have given me permission to publish details of their cases ; to their house surgeons; to Dr. G. A. Harrison and Dr. H. E. Archer, for their advice and assistance ; and to the nursing staff, especially to Miss Capon. REFERENCES
Colebrook, L., and Kenny, M. (1936a) Lancet, 1, 1279. (1936b) Ibid, 2, 1319. Buttle, G. A. H., and O’Meara, R. A. Q. (1936) Ibid, 2, 1323. M. Foulis, A., and Barr, J. B. (1937) Brit. med. J. Feb. 27th, —
—
—
p. 445.
Frost, L. D. B. (1937) Lancet, Feb. 27th, p. 510. Fuller, A. T. (1937) Ibid, Jan. 23rd, p. 194. Harrison, G. A. (1930) Chemical Methods in Clinical Medicine,
London, 1930. Thomas, J. McQ. (1937) Proc. R. Soc. Med. 30, 410. Tréfouel, J., and Mme. Nitti, F., and Bovet, D. (1935) C. R. Soc. Biol. Paris, 120, 736. Van den Bergh, A. A. H., and Revers, F. E. (1931) Dtsch. med. Wschr. 57, 706.
Clinical and Laboratory Notes COMA AS THE FIRST SYMPTOM OF
DIABETES BY E. FRETSON
SKINNER, M.D. Camb.,
F.R.C.P. Lond. PHYSICIAN TO THE SHEFFIELD ROYAL HOSPITAL
DIABETIC coma, in spite of insulin, is very often fatal and usually presents difficulties. The case to be described may be of interest, because it showed one feature that I had always considered a sign that death was certain-namely, commencing anuriabut nevertheless ended in recovery. So far as could be ascertained, the patient’s symptoms began on Thursday, May 30th, with headache and vomiting which were ascribed to dietary indiscretions by her medical man; he ordered a simple laxative regime. Nothing unusual happened until the following Tuesday afternoon (June 4th) when a kind of delirium set in and the doctor was sent for again. She was a woman of 28 ; the age, sex, and various other circumstances suggested a diagnosis of hysteria, but he was not satisfied that this was really the condition. As she did not improve he asked me to see her the same evening. When I arrived at about 9 P.M. she was lying in bed, semi-conscious and talking nonsense. She had a dry cracked tongue, dry skin, and breath smelling strongly of acetone. By this time the diagnosis was clearly one of diabetic coma and she was sent to hospital at once. The urine had been examined three days previously, when her illness began, and had been found free from sugar and albumin. When she reached hospital, about 10 r.M.,I found the urine (catheter) contained a very large amount of diacetic acid and 8 per cent. of glucose. A blood-sugar estimation, made while the ordinary routine preliminary coma treatment of rectal washouts and glucose-saline enemas was being carried out, gave a reading of 0’57 per cent. (Folin and Wu’s method). As she was still just rousable, hot saline and 10 per cent. glucose with 5 per cent. bicarbonate of soda was given by mouth almost continuously, and her
instructed that she must be made to drink at least three pints of this hot saline before morning. At the same time 60 units of insulin was given immediately, to be followed by another 60 units in two hours. As this did not lessen the depth of coma an attempt was nurse was